Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Nutex Health has become a high profile healthcare stock after a very large 3 year return, and the question now is whether that market price lines up with what the business is earning. With the move influenced by both operational progress and fresh risks, the key issue for anyone looking at Nutex Health is how much of its earnings power is already reflected in the current valuation. Over the past 3 years Nutex Health has delivered a very large share price gain, which puts extra pressure on...
Nutex Health (NUTX) just secured approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin around September 23, 2026. This move may broaden liquidity and investor access. Recent trading has been choppy for Nutex Health, with the share price slipping 3.33% over the last day and 5.81% across the past week, even after a 30 day share price return of 7.32% and a 90 day gain of 21.31%, which leaves momentum still positive overall. Look beyond Nutex Health and review how...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.